Continuous Infusion Vancomycin Through the Addition of Vancomycin to the Continuous Renal Replacement Therapy Solution in the PICU: A Case Series

Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
Jeffrey J CiesArun Chopra

Abstract

To describe our experience with achieving therapeutic serum vancomycin concentrations in pediatric continuous renal replacement therapy by using continuous infusion vancomycin by mixing vancomycin into the continuous renal replacement therapy solution. Retrospective chart review. A 189-bed, freestanding children's tertiary care teaching hospital in Philadelphia, PA. Pediatric patients receiving continuous renal replacement therapy from April 1, 2009, through December 31, 2014. None. There were a total of 21 patients who received continuous renal replacement therapy during the study period. Of these, 11 (52.3%) received vancomycin in the continuous renal replacement therapy solution. The median (range) concentration of vancomycin added to the continuous renal replacement therapy solution was 25 mg/L (18-35 mg/L). The mean vancomycin plateau level was 22.8 ± 3.3 mg/L. All patients achieved a serum vancomycin plateau level that was greater than 15 mg/L. There were no adverse events related to the addition of vancomycin to the continuous renal replacement therapy solution. The addition of vancomycin to the continuous renal replacement therapy solution(s) is an effective modality that is used for delivering vancomycin continuous inf...Continue Reading

References

Nov 1, 1988·Critical Care Medicine·M M PollackP R Getson
Jun 1, 1994·Clinical Pharmacokinetics·F BressolleM Galtier
Jun 19, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M S JoyP M Palevsky
Aug 18, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C RoncoZ Ricci
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rodger D MacArthurWilliam Barchuk
Mar 20, 2004·Nature Reviews. Microbiology·George L Drusano
Aug 26, 2004·British Journal of Clinical Pharmacology·Megan E DelDotSusan E Tett
Oct 21, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Allan R TunkelRichard J Whitley
Oct 25, 2006·Archives of Internal Medicine·Levita K HidayatAnnie Wong-Beringer
Mar 31, 2007·Kidney International·A Akcan-ArikanS L Goldstein
Apr 10, 2008·International Journal of Clinical Pharmacology and Therapeutics·M VázquezC Maldonado
May 3, 2008·Archives of Disease in Childhood. Fetal and Neonatal Edition·O PlanJ C Picaud
Dec 25, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Michael RybakDonald P Levine
Jan 23, 2009·Journal of the American Society of Nephrology : JASN·George J SchwartzSusan L Furth
Jun 12, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Catherine D KrawczeskiPrasad Devarajan
Oct 30, 2010·The Pediatric Infectious Disease Journal·Jennifer A MuszynskiMark W Hall
Jan 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuUNKNOWN Infectious Diseases Society of America
Sep 2, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John S BradleyUNKNOWN Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
Oct 27, 2011·The Journal of Antimicrobial Chemotherapy·Maria Adriana CataldoNicola Petrosillo
Feb 16, 2012·International Journal of Antimicrobial Agents·Eva Ocampos-MartinezFabio Silvio Taccone
Mar 6, 2012·International Journal of Antimicrobial Agents·João Pedro BaptistaJorge M Pimentel
Mar 27, 2012·Clinical Nephrology·F Perry Wilson, Jeffrey S Berns
May 19, 2012·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Amanda B HassingerEric L Wald
Jul 4, 2012·Annals of Intensive Care·Bruno Van HerendaelMargareta Ieven
Nov 23, 2012·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Susan McKamyPeter J Ambrose
Jan 15, 2013·International Journal of Antimicrobial Agents·Cecilia CovajesFabio Silvio Taccone
Feb 6, 2013·Archivos argentinos de pediatría·Brenda Lara ZylbersztajnSilvina Ruvinsky
Jun 27, 2013·The Journal of Antimicrobial Chemotherapy·Marjorie BeumierFabio Silvio Taccone
Jan 1, 2014·The Pediatric Infectious Disease Journal·Amanda GweeNigel Curtis

❮ Previous
Next ❯

Citations

Aug 6, 2019·British Journal of Clinical Pharmacology·Natasha SosninAmanda Gwee
Apr 5, 2016·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Geoffrey M Fleming, Bruce A Mueller
Mar 25, 2017·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Jeffrey J CiesArun Chopra
Apr 9, 2020·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Heather L Girand
Apr 3, 2019·European Journal of Clinical Pharmacology·Brady S MoffettAyse Akcan Arikan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
Ali S OmraniWafa A Alfahad
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
Katie M McCallisterMark Rayburn
Revista da Associação Médica Brasileira
Paulo Roberto Antonacci CarvalhoP Lago
© 2022 Meta ULC. All rights reserved